Latest Innovation News

XPON Technologies Group has acquired Alpha Digital for $1.72 million upfront plus performance earn-ins, immediately adding $4 million in recurring revenue and fast-tracking its path to profitability.

Next Science Limited has successfully had a derivative complaint dismissed in Florida, while continuing legal action against former employees for breach of post-employment restraints.

Barton Gold Holdings has released an Optimised Scoping Study for its Tunkillia Gold Project, revealing significant improvements in project economics, including a sub-one-year payback and reduced capital expenditure. The study paves the way for accelerated feasibility work and funding efforts.

PlaySide Studios announces the resignation of co-founder and Creative Director Gerry Sakkas, who will also leave the board. The company will not replace his role following a recent restructure, while Sakkas commits to a significant share escrow.

Immutep’s combination of eftilagimod alfa (efti) and KEYTRUDA® delivers a striking 17.6-month median overall survival in head and neck cancer patients with low PD-L1 expression, a group with limited treatment options.

Westpac Banking Corporation reported a slight 1% decline in net profit to $3.3 billion for the first half of 2025, while business and institutional lending grew robustly. The bank maintained a solid capital position and announced a fully franked interim dividend of 76 cents per share.

Westpac Banking Corporation posted a $3.5 billion net profit for the first half of 2025, maintaining strong capital ratios and advancing its digital transformation and sustainability initiatives despite a slight earnings dip.

Westpac Banking Corporation posted a slight 1% decline in net profit for the first half of 2025, underpinned by strong growth in business and institutional lending and a resilient balance sheet amid global volatility.

Westpac Banking Corporation reported a modest 1% decline in net profit to AUD 3.317 billion for the six months ended March 2025, maintaining its interim dividend and advancing key digital and sustainability initiatives.

SenSen Networks has extended its contract with Brisbane City Council for kerb management and enforcement solutions, including a large-scale rollout of its innovative SenPIC technology, in a deal valued at an estimated $8 million over four years.

Opyl Limited has successfully raised $1.5 million through an oversubscribed placement to accelerate the growth of its AI-driven clinical trial platform, Trialkey. The capital injection underscores strong investor confidence as the company prepares for a pivotal expansion phase.

Nyrada Inc. has cleared the Safety Review Committee’s scrutiny for its Phase I clinical trial, progressing to the third dosing cohort of its promising neuroprotective and cardioprotective drug candidate NYR-BI03.